EXAS: Exact Sciences Corporation Stocks News on July 27, 2024

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?

EXAS

Zacks

a day ago

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?

EXAS

Zacks

2 days ago

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

EXAS

Insider Monkey

11 days ago

Exact Sciences Corporation (EXAS) Slipped Over Investors’ Concerns

Geneoscopy’s ColoSense deemed reliable in published study

EXAS

Medical Device Network

16 days ago

Geneoscopy’s ColoSense deemed reliable in published study

This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street

EXAS

Motley Fool

18 days ago

This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street

Exact Sciences schedules second quarter 2024 earnings call

EXAS

Business Wire

19 days ago

Exact Sciences schedules second quarter 2024 earnings call

People Are Feeling Stuck in Their Jobs. Bosses Are Starting to Worry.

EXAS

The Wall Street Journal

20 days ago

People Are Feeling Stuck in Their Jobs. Bosses Are Starting to Worry.

EXAS

MT Newswires

a month ago

Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target

EXAS

MT Newswires

a month ago

BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating

NGS: the road to personalising cancer care

EXAS

Medical Device Network

a month ago

NGS: the road to personalising cancer care

MGI and SeqOne partner to create end-to-end genomic testing platform

EXAS

Medical Device Network

a month ago

MGI and SeqOne partner to create end-to-end genomic testing platform

Is It Time to Buy May's Worst-Performing Nasdaq Stocks?

EXAS

Motley Fool

a month ago

Is It Time to Buy May's Worst-Performing Nasdaq Stocks?

EXAS

Zacks

2 months ago

Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?

EXAS

Simply Wall St.

2 months ago

Exact Sciences (NASDAQ:EXAS) shareholders have endured a 63% loss from investing in the stock three years ago

Illumina names Everett Cunningham as chief commercial officer

EXAS

MedTech Dive

2 months ago

Illumina names Everett Cunningham as chief commercial officer

EXAS

Insider Monkey

2 months ago

Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential?

EXAS

Zacks

2 months ago

Exact Sciences (EXAS) Witnesses Rising Expenses, Competition

EXAS

Zacks

2 months ago

Exact Sciences (EXAS) to Showcase Favorable Research Outcome

Exact Sciences to Participate in June Investor Conferences

EXAS

Business Wire

2 months ago

Exact Sciences to Participate in June Investor Conferences

Hedge Funds are Bullish on This Cancer Stock

EXAS

Insider Monkey

2 months ago

Hedge Funds are Bullish on This Cancer Stock

Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok

EXAS

The Wall Street Journal

2 months ago

Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok

EXAS

MT Newswires

2 months ago

Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test

FDA panel backs Guardant’s blood test for colon cancer

EXAS

MedTech Dive

2 months ago

FDA panel backs Guardant’s blood test for colon cancer

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®

EXAS

Business Wire

2 months ago

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®

Exact Sciences Earns 2024 Great Place To Work® Certification™

EXAS

Business Wire

2 months ago

Exact Sciences Earns 2024 Great Place To Work® Certification™

EXAS

MT Newswires

2 months ago

Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed

Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy

EXAS

Business Wire

2 months ago

Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy

EXAS

Simply Wall St.

3 months ago

Exact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

EXAS

GuruFocus.com

3 months ago

Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss

UK NICE backs Exact’s Oncotype cancer genomic test

EXAS

Medical Device Network

3 months ago

UK NICE backs Exact’s Oncotype cancer genomic test

Exact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

EXAS

Simply Wall St.

3 months ago

Exact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On 'Overblown' Growth Concerns

EXAS

Investor's Business Daily

3 months ago

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On 'Overblown' Growth Concerns

EXAS

Morningstar Research

3 months ago

Analyst Report: Exact Sciences Corporation

EXAS

Insider Monkey

3 months ago

Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript

EXAS

Zacks

3 months ago

Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down

EXAS

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Exact Sciences Corp Earnings Call

EXAS

GuruFocus.com

3 months ago

Exact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...

EXAS

GuruFocus.com

3 months ago

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight

EXAS

Motley Fool

3 months ago

Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript

EXAS

Zacks

3 months ago

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

EXAS

Associated Press Finance

3 months ago

Exact Sciences: Q1 Earnings Snapshot

Exact Sciences Announces First-Quarter 2024 Results

EXAS

Business Wire

3 months ago

Exact Sciences Announces First-Quarter 2024 Results

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024

EXAS

Business Wire

3 months ago

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024

Techne (TECH) Q3 Earnings and Revenues Beat Estimates

EXAS

Zacks

3 months ago

Techne (TECH) Q3 Earnings and Revenues Beat Estimates

Exact Sciences to Participate in May Investor Conference

EXAS

Business Wire

3 months ago

Exact Sciences to Participate in May Investor Conference

EXAS

Morningstar Research

3 months ago

Analyst Report: Exact Sciences Corporation

EXAS

Zacks

3 months ago

Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note

EXAS

Insider Monkey

3 months ago

Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)

EXAS

Zacks

3 months ago

Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?

EXAS

Insider Monkey

3 months ago

10 Best Performing Biotech ETFs in 2024

EXAS

Zacks

3 months ago

Why Exact Sciences (EXAS) Dipped More Than Broader Market Today

EXAS

Simply Wall St.

3 months ago

Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook

EXAS

MedTech Dive

3 months ago

Exact Sciences names Aaron Bloomer CFO

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

EXAS

Business Wire

3 months ago

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

EXAS

Insider Monkey

3 months ago

Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1

Myriad Genetics (MYGN) Announces Favorable Research Results

EXAS

Zacks

3 months ago

Myriad Genetics (MYGN) Announces Favorable Research Results

EXAS

Zacks

4 months ago

Zacks Investment Ideas feature highlights: Exact Sciences, Kaiser Aluminum and Atmus Filtration Technologies

Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

EXAS

Business Wire

4 months ago

Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Stock Moves -0.89%: What You Should Know

3 Buy-Rated Stocks Flexing Relative Strength

EXAS

Zacks

4 months ago

3 Buy-Rated Stocks Flexing Relative Strength

Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure

EXAS

Barrons.com

4 months ago

Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure

EXAS

TipRanks

4 months ago

ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?

EXAS

Insider Monkey

4 months ago

11 Best Biotech ETFs To Buy

Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024

EXAS

Business Wire

4 months ago

Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024

Sorry, but Blood Tests Won’t Replace Stool Samples or Colonoscopies Yet

EXAS

The Wall Street Journal

4 months ago

Sorry, but Blood Tests Won’t Replace Stool Samples or Colonoscopies Yet

Exact Sciences Schedules First Quarter 2024 Earnings Call

EXAS

Business Wire

4 months ago

Exact Sciences Schedules First Quarter 2024 Earnings Call

Freenome’s colorectal cancer blood test data underwhelm analysts

EXAS

MedTech Dive

4 months ago

Freenome’s colorectal cancer blood test data underwhelm analysts

1 Beaten-Down Cathie Wood Stock to Buy and Hold

EXAS

Motley Fool

4 months ago

1 Beaten-Down Cathie Wood Stock to Buy and Hold

Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment

EXAS

Business Wire

4 months ago

Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment

EXAS

Zacks

4 months ago

Exact Sciences' (EXAS) Oncoguard Esophagus Test Looks Promising

Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales

EXAS

Investor's Business Daily

4 months ago

Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales

Exact Sciences, Mayo Clinic share early data on esophageal cancer test

EXAS

MedTech Dive

4 months ago

Exact Sciences, Mayo Clinic share early data on esophageal cancer test

Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?

EXAS

Zacks

4 months ago

Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?

Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer

EXAS

Business Wire

4 months ago

Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

EXAS

Business Wire

4 months ago

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

EXAS

Zacks

4 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

EXAS

Zacks

4 months ago

How Much Upside is Left in Exact Sciences (EXAS)? Wall Street Analysts Think 53.83%

Here's How Much You'd Have If You Invested $1000 in Exact Sciences a Decade Ago

EXAS

Zacks

4 months ago

Here's How Much You'd Have If You Invested $1000 in Exact Sciences a Decade Ago

EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Up 4.2% Since Last Earnings Report: Can It Continue?

EXAS

Simply Wall St.

4 months ago

Exact Sciences Corporation (NASDAQ:EXAS) is largely controlled by institutional shareholders who own 89% of the company

EXAS

Zacks

4 months ago

Exact Sciences' (EXAS) BLUE-C Study Results Published in NEJM

Guardant posts data for colon cancer blood test amid push from rivals

EXAS

MedTech Dive

4 months ago

Guardant posts data for colon cancer blood test amid push from rivals

Cathie Wood Darling Exact Sciences, And Rival Guardant Health, Dip On Colon Cancer Updates

EXAS

Investor's Business Daily

4 months ago

Cathie Wood Darling Exact Sciences, And Rival Guardant Health, Dip On Colon Cancer Updates

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

EXAS

Business Wire

4 months ago

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

EXAS

Zacks

5 months ago

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

2 Beaten-Down Cathie Wood Stocks With Massive Potential

EXAS

Motley Fool

5 months ago

2 Beaten-Down Cathie Wood Stocks With Massive Potential

EXAS

Zacks

5 months ago

Can Exact Sciences (EXAS) Climb 55.43% to Reach the Level Wall Street Analysts Expect?

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

EXAS

Zacks

5 months ago

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer

EXAS

Business Wire

5 months ago

Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer

EXAS

GuruFocus.com

5 months ago

Exact Sciences Corp (EXAS) Director Daniel Levangie Sells 5,000 Shares

The Top 3 Healthcare Stocks to Buy on Weakness in 2024

EXAS

InvestorPlace

5 months ago

The Top 3 Healthcare Stocks to Buy on Weakness in 2024

7 Stable Stocks to Buy for 100% Returns by 2025

EXAS

InvestorPlace

5 months ago

7 Stable Stocks to Buy for 100% Returns by 2025

Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices

EXAS

InvestorPlace

5 months ago

Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices

Exact Sciences to Participate in March Investor Conference

EXAS

Business Wire

5 months ago

Exact Sciences to Participate in March Investor Conference

EXAS

Morningstar Research

5 months ago

Analyst Report: Exact Sciences Corporation

Exact Sciences Full Year 2023 Earnings: EPS Beats Expectations

EXAS

Simply Wall St.

5 months ago

Exact Sciences Full Year 2023 Earnings: EPS Beats Expectations

EXAS

Insider Monkey

5 months ago

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2023 Earnings Call Transcript

EXAS

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Exact Sciences Corp Earnings Call

EXAS

Zacks

5 months ago

Exact Sciences (EXAS) Q4 Loss Narrows, Revenues Rise Y/Y

EXAS

Motley Fool

5 months ago

Latest Exact Sciences Corporation (EXAS) News on July 27, 2024

Share on Social Networks: